European regulators have given Diabeloop CE mark approval for its DBLG1 technology, a self-learning and customizable device for monitoring and maintaining glucose levels. The system, which can imitate the insulin-dispensing functions of the pancreas, connects to an insulin patch pump and a continuous blood glucose monitoring system to predict glucose levels and enable optimal pump control.